oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy is a research paper published in Molecular Therapy — Oncolytics (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: / NCI P01CA163205
Cancer Prevention and Research Institute of Texas
Grant: RP210045
Cancer Prevention and Research Institute of Texas
Grant: RP180734
National Institute of Neurological Disorders and Stroke
Grant: R61NS112410
National Institute of Neurological Disorders and Stroke
Grant: R01 NS127473
NCI NIH HHS
Grant: P01 CA163205
National Institutes of Health
Grant: 3P01CA163205-03S1
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
National Institutes of Health
Grant: 5R01NS127473-03
Next Gen Virotherapy for GBM
National Institutes of Health
Grant: 5R61NS112410-02
Optimizing oncolytic virus therapy for glioblastoma
NIH
FWCI
2.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals